COLET: A multistage, phase 2 study evaluating the safety and efficacy of cobimetinib in combination with paclitaxel as first-line treatment for patients with metastatic triple-negative breast cancer

Authors
Category Primary study
JournalCancer Research
Year 2016
This article has no abstract
Epistemonikos ID: dd8d9d1dc85c500c5d19db037332d00263678b35
First added on: Feb 07, 2025